from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0919/-

LFCtreatmentdescriptionclass of inhibitor

-0.536

Amikacinug/mL Amikacintranslation

-0.025

Cap5-10ug/mL Capreomycintranslation

-0.074

Rox10-50 ug/mL Roxithromycintranslation

-0.804

SM2-5 ug/mL Streptomycintranslation

-0.631

Tet5-10 ug/mL Tetracyclinetranslation

0.463

Rif0.2-5ug/mL Rifampicintranscription

0.298

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.473

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.266

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.108

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.464

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.808

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.204

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.724

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.003

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.415

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.189

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.595

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.112

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.140

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.378

KCN5-20 ug/mL Potassium cyaniderespiration

-0.316

NaN30.2-2 mM Sodium aziderespiration

-0.303

Nigericin50 uM Nigericinrespiration

0.391

TRC10-150 ug/mL Triclosanrespiration

-0.064

TRZ10-25 ug/mL Thioridazinerespiration

1.052

Valinomycin0.5-10 uM Valinomycinrespiration

-2.683

ZnSO42 mM ZnSO4respiration

0.609

menadione6-10 ug/mL Menadionerespiration

-0.448

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.870

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.176

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.536

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.473

NRP_1Non-replicating persistence stage 1dosRassociated

-0.151

Amp0.2mg/mL AmpicillincellWall

-1.103

Cephalexin20-100 ug/mL CephalexincellWall

-0.529

Cerulenin0.32-5 ug/mL CerulenincellWall

0.205

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.214

EMB10-20 ug/mL EthambutolcellWall

-0.888

Eta12-40 ug/mL EthionamidecellWall

-1.574

INH0.2-0.4 ug/mL IsoniazidcellWall

0.420

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.404

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.029

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.831

BZA0.12 mg/mL BenzamidearomaticAmides

0.152

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.294

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.394

H2O24 mM hydrogen peroxideDNAdamaging

-0.314

Levo10 ug/mL LevofloxacinDNAdamaging

0.236

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.426

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.706

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.504

UVUV-irradiationDNAdamaging

0.207

ARP41-4 ug/mL Antitubercular compound ARP4?

0.120

Antimycin12.5-50 ug/mL Antimycin A?

0.686

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.057

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.382

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.403

PA8240.2-2 ug/mL PA-824?

-0.204

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.516

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.271

Verapamil50 uM Verapamil?

0.378

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.288

methoxatin10-20 ug/mL Methoxatin?